GRIFOLS SHARED SERVICES NORTH AMERICA, INC.

Lobbying for GRIFOLS SHARED SERVICES NORTH AMERICA INC

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 11, 2025

Expenses

$360,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

S 694
PLASMA Act
HR 1476
PLASMA Act
HR 1143
Medicare IVIG Access Enhancement Act of 2025
HR 2343
John W. Walsh Alpha-1 Home Infusion Act of 2025
HR 2172
Preserving Patient Access to Home Infusion Act

Lobbying activity 2

Health Issues

S. 694 & H.R. 1476, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 1143, Medicare IVIG Access Enhancement Act of 2025. H.R. 2343, John W. Walsh Alpha-1 Home Infusion Act of 2025. H.R. 2172, Preserving Patient Access to Home Infusion Act. Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act.

Immigration

Issues related to immigration policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.